BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Ubie and Nucleus Genomics Partner to Expand Access to Genetic Screening and Early Disease Detection

Genetic testing can be critical to ensuring the early diagnosis and proper treatment of serious disease for patients of all ages The partnership combine...

February 28, 2025 | News

Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical...

February 27, 2025 | News

HBM Alpha Therapeutics Secures $395M Licensing Deal to Advance CRH-Targeting Therapy

HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaborati...

February 26, 2025 | News

Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business for $4.1 Billion in Cash

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that the company has en...

February 25, 2025 | News

Chime Biologics and Mabgeek Advance MG-K10 to U.S. Phase III Trials for Atopic Dermatitis and Asthma

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, announced its continued collaboration with Mabgeek ...

February 24, 2025 | News

Harbour BioMed and Insilico Medicine Partner to Accelerate AI-Driven Antibody Discovery

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on...

February 21, 2025 | News

Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute’s CNS Capsids to Advance Gene Therapy for Neurological Diseases

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expand...

February 21, 2025 | News

Ascletis’ ASC30 Oral Tablet Shows Promising Weight Loss in U.S. Phase Ib Obesity Trial

- ASC30 oral once-daily tablet demonstrated a 6.3% mean body weight reduction from baseline after 28-day treatment in multiple ascendi...

February 20, 2025 | News

GenScript Biotech Commits to Aggressive Carbon Reduction Targets Verified by SBTi

GenScript Biotech Corp, a global leader in life sciences R&D and manufacturing services, today announced that it is committing to aggressive carbon emi...

February 19, 2025 | News

Merck KGaA Reshapes Leadership for the Future with Key Executive Moves

Appointment of three internal senior executives ensures strategic continuity with a new era of leadership Jean-Charles Wirth to become CEO Life Scienc...

February 18, 2025 | News

RemeGen Presents Promising Phase II Trial Results for Disitamab Vedotin and Toripalimab in Muscle-Invasive Bladder Cancer at ASCO GU 2025

RemeGen Co., Ltd. (RemeGen) has announced new efficacy and safety data from the Phase II clinical trial (NCT05297552, Study ID: RC48-C017) evaluating Disit...

February 17, 2025 | News

Australia’s Navi Medical Technologies secures FDA clearance for Neonav ECG Tip Location System expanding pediatric vascular access in the US Victoria and globally

Navi Medical Technologies has announced that its Neonav® ECG Tip Location System has received 510(k) clearance from the U.S. Food and Drug Administrati...

February 17, 2025 | News

Innovent’s IBI363 Secures Second FDA Fast Track Designation for Advanced Lung Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...

February 17, 2025 | News

Stryker Unveils ProCeed Hospital Bed to Enhance Patient Care and Ease Caregiver Burden

Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the ProCeed hospital bed, offering simplicity while enhancing care acr...

February 17, 2025 | News

Stay Connected